Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$109.91
+3.40%
Mkt Cap $4.35B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
Implied Upside
+4.6%
Consensus $115.00 vs current $109.91
NASDAQ·Healthcare·Biotechnology
$109.91
+3.40%
Mkt Cap $4.35B
Buy
10
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
+4.6%
Consensus $115.00 vs current $109.91